To assess whether it is safe and outcome of drainage of fluid in the lungs of patients with cirrhosis.
Phase 3
- Conditions
- Health Condition 1: K769- Liver disease, unspecified
- Registration Number
- CTRI/2023/09/057708
- Lead Sponsor
- Institute of Liver and Biliary Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Age 18-75 years
2.CLD with refilling symptomatic hepatic hydrothorax
Exclusion Criteria
1.CTP >12, MELD >25
2.Tubercular PE, Ischemic cardiac disease
3.If opting for TIPS/ LT
4.Severe HPS
5.Prior or current SBE/ SBP, septic shock
6.Patients on mechanical ventilator
7.Serum Creatinine >2 mg/dl
8.Extrahepatic malignancy
9.Serum Sodium < 120
10.Post TIPS/ BRTO/ SAE patients
11.Post renal or liver transplantation
12.Lack of informed consent
13.Hepatocellular carcinoma outside milan criteria.
14.Non-cirrhotic portal HT
15.Known HIV infection
16.Pregnant women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method o of patients requiring repeated thoracocentesis in both armsTimepoint: Day 30 & 90
- Secondary Outcome Measures
Name Time Method